Each day at argenx, we are motivated to pursue a better tomorrow alongside patients. We aim to do this through partnership because we know that "together we are better". As your ally, we pioneer innovations to advance the understanding of rare diseases; we want to deliver immunology treatments to patients worldwide.
We listen to patients, supporters and advocacy communities; we hear your stories and share your determination.
We integrate your aspirations into how we innovate, how we conduct research and design trials, and how we can support you in the daily struggles you face living with a rare disease.
There is a common purpose across argenx that is driven by your resilience and we welcome this opportunity to be with you on this journey.
The immune system is the body’s defense system against infection and other diseases. In the case of autoimmune diseases, the immune system mistakenly identifies part of its own body as an invader and produces antibodies to attack its tissues and cells. In many cases, it is not known what causes the immune system to initiate this autoimmune response.
argenx Canada is currently focused on generalized Myasthenia Gravis, an IgG mediated disease.
For more information on diseases, find here additional resources and links to advocacy organizations.
